Announcement of non-core asset partnership
Resolves: Odyssey Therapeutics executes a strategic partnership, licensing agreement, or collaboration deal for a non-core asset.
sec_filing· Corporate Finance
Announcement of non-core asset partnership
Market overview
Derived from Odyssey Therapeutics, Inc. (ODTX) (CIK 0001882782) 8-K filing analysis
Corporate Finance prediction market
- Implied probability (Yes)
- 55%
- Closes
- 2027-03-31
About this prediction
Resolution criteria
Odyssey Therapeutics executes a strategic partnership, licensing agreement, or collaboration deal for a non-core asset.
More Corporate Finance markets
- AMAL initiates share repurchases under new program by Q1 2027 — 85% Yes
- GPI Share Repurchase Announcement — 65% Yes
- TCBX increases share repurchase authorization before 2027 — 65% Yes
- Capital Restructuring Announcement — 60% Yes
- TCBX completes at least $5M of share repurchases by Q1 2027 — 85% Yes
- Will Integrated Rail & Resources raise over $50M in capital by mid-2027? — 65% Yes
- Will Nuburu secure additional capital financing by Q1 2027? — 65% Yes
- Will Adial Pharmaceuticals initiate further equity financing before April 2027? — 65% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…